Australian Product InformationONCASPAR pegaspargase lyophilised Version 4 1/20 AUSTRALIAN PRODUCT INFORMATION ONCASPAR pegaspargase powder for solution for injection/infusion 1 NAME OF THE MEDICINE Pegaspargase 2 QUALITATIVE AND QUANTITATIVE COMPOSITION ONCASPAR pegaspargase is a modified version of the enzyme asparaginase
The hallmark of Tasman Health Care is keeping high quality of care through the commitment of their physicians staff and community partners Tasman Health Care is committed to providing patients with access to new oncology treatment opportunities through the integrated Consultancy rooms Tasman Health Care Day Infusion Unit Tasman Oncology Research unit and the Tasman Health Care
Private Day Infusion and Oncology Centre Located on the Mornington Peninsula and southern Melbourne Frankston private Hospital s Infusion Centre is a treatment facility designed to provide cancer care in a bright and relaxed environment
Infusion Resource Library Our wide range of resources can help you understand use and optimize our products FAQs/Tip sheets Directions for Use White papers View full library Please note not all products services or features of products and services may be available in your local area Please check with your local BD representative
Australia New Zealand Browse all products We support the healthcare industry with market leading products and services that aim to improve care while lowering costs Infusion devices Oncology Oncology Put safety first with our closed system solutionhelping to protect you from exposure to hazardous drugs
Home Infusion EMR Safer more efficient more effective care EpiSoft s cloud based EMR and practice management solution is the only software in the Australian market capable of supporting every facet of the complex requirements of home infusion services from e prescribing compounded medication order scheduling and safe at home drug administration
Find your ideal job at SEEK with 1 Melbourne Oncology Home Infusion Services job found in All Australia View all our Melbourne Oncology Home Infusion Services vacancies now with
Ensuring the patient safety requires ready access to quality products that make a clinical difference Every day At ICU Medical we consistently and reliable provide you the IV therapy products you need to provide the quality of care your patients deserve
BeiGene announces inclusion of three innovative oncology products in China National Reimbursement Drug List NRDL Infusion Related Reactions the United States Australia
Australia België Belgique Danmark Deutschland España Drug Preparation Oncology products Dressings Securement Stopcock extension lines manifolds and stopcocks Gravity infusion set 2000E7D SmartSite needle free valve SmartSite Stopcock 60643 Alaris GP Series Primary infusion set with 15μm chamber filter
AUSTRALIAN PRODUCT INFORMATIONACLASTA zoledronic acid Solution for Injection 1 NAME OF THE MEDICINE Zoledronic acid 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Aclasta 5 mg/100 mL solution for infusion contains 5 mg zoledronic acid anhydrous corresponding to 5 330 mg zoledronic acid monohydrate Contains sodium and sulfites
You are about to leave the site operated by B Braun Australia Pty Ltd and B Braun New Zealand You will be redirected to a site operated by one of its related corporations The site to which you are redirected has been designed to comply with the laws of the jurisdiction in which the related corporation operates
AngioDynamic is a global provider of industry leading medical devices for oncology care venous therapy vascular interventions dialysis and ablation including midlines PICCs and ports
We cannot provide detailed information about our prescription medicines on this website in compliance with regulations Our medicines are approved in individual countries for specific uses and the information we provide for patients is governed by local regulations
To judge the quality and value of the Q FLO technology you can study the features and benefits study the marketing materials look at the standards it meets and exceeds and review the Infusion Innovations team behind it all But the most important validation of the value of the product comes from customers
The unsafe handling of hazardous drugs used to treat many forms of cancer poses a significant health hazard to healthcare workers and patients In response to these risks ICU Medical has developed oncology systems closed system transfer devices CSTDs automated compounding technologies smart infusion pumps and safety software
Ambulatory Infusion provides solutions across the continuum of care from Hospital to Homecare based on a single versatile platform Ambulatory Infusion View 9 View 30 View 60 View 90 View 9 View 9 View 30 View 60 View 90 Showing 1 9 of 14
Infusion therapy made clean safe and simple We offer a full range of IV sets and accessories for infusion We also offer closed systems for cytotoxic drug delivery to minimise the health risks associated with the handling of hazardous agents
Acknowledging this was a retrospective analysis that was not designed to confirm the safety of a 30 minute infusion Abada said the results indicate that the commonly held perception that immediate reactions are related to infusion rate warrants further investigation Clinical Oncology News Staff
At Janssen we aim to fundamentally alter the way cancer is understood diagnosed and managed We re committed to delivering new transformational medicines and we re determined to redefine the standard of care Our discoveries have produced new therapeutic options in prostate cancer haematological malignancies lung cancer and colorectal cancer
Oncology Delivery Equashield is a completely airtight leakproof and user friendly Closed System Transfer Device that protects you and your staff from hazardous drug leaks sprays or aerosols that may be created during drug preparation administration and disposal Clinically Proven With countless published studies validating the safety and
Needle Free Connectors Set Length 270 cm Priming Volume 25 ml Bore 3 mm 1 Spike s Vented/Unvented Drops per ml 20 Hydrophobic Air Inlet Filter with Cap 15 µm Drip Chamber Filter 2 SmartSite Valve Y Port
Medical InformationAdverse Events or Product Quality Complaints In the U S to report an adverse event related to use of a Clovis product or if you have a product quality complaint please contact the Medical Information department at US toll 1 844 CLVS ONC US toll free by email at medinfo clovisoncology or by using our website at
Participants from a trial at Westmead Hospital Sydney Australia using CAR T cells based on 4 1BB coreceptor instead of CD28 and the piggyBAC system for gene modification Development of a single cell multiomics approach was used to study the molecular functional and transcriptomic profile of CAR T cells in the pre infusion product and the
Infusion therapy made clean safe and simple We offer a full range of IV sets and accessories for infusion We also offer closed systems for cytotoxic drug delivery to minimise the health risks associated with the handling of hazardous agents Explore IV Lines and Fluid Therapy Oncology Delivery Equashield is a completely airtight leakproof
ASCO and some oncologists express concerns about safety With hospitals dramatically reducing in person visits during COVID 19 there has been an increased emphasis on telehealth and home care with care teams at many cancer centers switching some patients to oral oncology medications instead of infused therapy and expanding home infusion services
Infusion Products Smiths Medical delivers intelligent infusion technologies to meet your needs from Acute to Alt Site to Homecare Smiths Medical offers infusion systems including pumps disposables and software View 9 View 30 View 60 View 90 View 9
Australia s first CAR T manufacturer Cell Therapies a company based at the Peter MacCallum Cancer Centre has started manufacturing Kymriah a chimeric antigen receptor T cell CAR T therapy approved by the TGA In a coup for Australia s cellular immunotherapy community Cell Therapies is one of seven sites in the world contracted by
Infusion Therapy Infusion therapy made clean safe and simple We offer a full range of infusion pumps IV sets and accessories for infusion and transfusion procedures in emergency surgery critical and intensive care units Also available are products for general hospital IV therapy and total parenteral nutrition TPN procedures
BeiGene announces inclusion of three innovative oncology products in China National Reimbursement Drug List NRDL Infusion Related Reactions the United States Australia
Our Products in Australia We are committed to bringing better health and a brighter future to patients by translating science into highly innovative medicines Our R D efforts are focused on four therapeutic areas Oncology Rare Diseases Neuroscience and Gastroenterology GI We also make targeted R D investments in Plasma Derived
REM SYSTEMS provides Oncology Systems for the safe preparation and delivery of hazardous drugs Clinically superior products to support the healthcare worker and improve efficiency Our range includes cytotoxic protective wear IV delivery systems and Closed System Transfer Devices to protect you and your staff from hazardous drug leaks sprays or aerosols that can be created during drug
Fresenius Kabi is specialized in the field of oncology products supported by integrated manufacturing regulatory sales marketing and distribution set up Fresenius Kabi has expertise for development and manufacturing of Active Pharmaceutical Ingredients API intermediates and dosage forms From the development of process technology to
Day oncology and infusion support services To ensure the best possible health outcome we also offer a wide range of support services important in the treatment and management of your health These include a range of wellness and exercise programs delivered by experienced dietitians physiotherapists and rehabilitation experts
Sunshine Coast University Private Hospital s Day Infusion Unit provides a range of services that can be completed in a day for the treatment of cancer and other conditions There are plans to attach inpatient beds to the unit in order to provide extended patient care
Our Day and Oncology Infusion Services has relocated to a brand new purpose built area Now located on 4th Floor 141 Grey St East Melbourne and co located with the Breast Surgery and Plastics unit The centre has expanded from 6 to 8 new electronically operated recliner chairs in beautiful light filled appointed surrounds